Metoprolol had already been identified by me as a life extending drug based on two human RCTs which reported mortality reductions in hypertensives that exceeded the standard mortality rate, as well as the control groups. PMID: 3293400, PMID: 1682683.
There is no indication that these hypertensives should have mortality rates better than the general population, therefore the bettering of the standard mortality rates makes these drugs anti-aging.
THE BENEFIT IS ABOUT 45% EQUALING BETTER THAN A SIX YEAR LIFE EXTENSION FOR HUMANS